Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of New Prognostic biomarkerRs in Patients With cirrhOsis diScharged After a hosPitalization Due to acutE deCompensation or acuTe-on-chronic Liver Failure

NCT06855056 is registered in ClinicalTrials.gov with European Foundation for Study of Chronic Liver Failure as lead sponsor.

NCT NCT06855056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06855056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of New Prognostic biomarkerRs in Patients With cirrhOsis diScharged After a hosPitalization Due to acutE deCompensation or acuTe-on-chronic Liver Failure
Lead sponsor
European Foundation for Study of Chronic Liver Failure
Phase
Observational
Overall status
Completed
Start date
March 1, 2025
Completion date
September 1, 2026
Enrollment
189 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

decompensated cirrhosis of liver, liver cirrhosis